Future Tech Ventures

Avoxt is creating advanced technologies for extremely efficient hydrogen production.

Cortalix is a biotechnological company focused on developing advanced diagnostics and therapeutics for conditions related to fibrosis and fibrotic cancers. The company specializes in creating PET-imaging diagnostics and targeted radiotherapeutics using its proprietary platform of synthetic single-domain antibodies. These tracers are designed to identify the extracellular domains of membrane receptors found on activated myofibroblasts, which are critical cells involved in various types of fibrosis, including lung, cardiac, kidney, and hepatic fibrosis, as well as fibrotic cancers like colon cancer. By partnering closely with other organizations, Cortalix aims to address significant medical needs and enhance treatment options for patients facing these challenging conditions.

IonIQs’ technology offers a solution by reducing water consumption and increasing efficiency for mining and refining companies.

SeaO2 is an ocean carbon removal startup that specializes in scalable technology designed to capture carbon dioxide (CO2) from seawater. By focusing on reducing CO2 concentrations in the ocean and indirectly in the atmosphere, the company aims to combat global warming. SeaO2 offers cost-effective solutions for atmospheric carbon removal, allowing clients to actively participate in mitigating climate change. Through its innovative approach, SeaO2 seeks to transform captured CO2 into viable business opportunities, contributing to the broader effort to reduce greenhouse gas emissions.